Variant report

Variant	esv3359671
Chromosome Location	chr21:45883424-45888122
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:32)
CpG islands
(count:247)
Chromatin interactive
region (count:5)
LncRNA
region (count:8)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:32 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr21:45885314-45885601	GM12878	blood:	n/a	n/a
2	EGR1	chr21:45885278-45885925	GM12878	blood:	n/a	n/a
3	FOSL2	chr21:45885239-45885927	HepG2	liver:	n/a	n/a
4	GABPA	chr21:45885295-45885921	Hela-S3	cervix:	n/a	n/a
5	IRF4	chr21:45885254-45885858	GM12878	blood:	n/a	n/a
6	IRF4	chr21:45885278-45886005	GM12878	blood:	n/a	n/a
7	JUN	chr21:45886941-45887068	HepG2	liver:	n/a	n/a
8	JUND	chr21:45885292-45886011	HepG2	liver:	n/a	n/a
9	JUND	chr21:45886854-45887099	HepG2	liver:	n/a	chr21:45886961-45886972
10	MYC	chr21:45885729-45885897	HUVEC	blood vessel:	n/a	n/a
11	MYC	chr21:45885522-45885644	MCF-7	breast:	n/a	n/a
12	MYC	chr21:45885301-45885511	MCF-7	breast:	n/a	n/a
13	NR3C1	chr21:45885337-45885922	A549	lung:	n/a	n/a
14	PAX5	chr21:45885585-45885786	GM12878	blood:	n/a	n/a
15	PAX5	chr21:45885281-45885564	GM12878	blood:	n/a	n/a
16	POLR2A	chr21:45885092-45885650	HepG2	liver:	n/a	n/a
17	POLR2A	chr21:45885973-45885989	Gliobla	brain:	n/a	n/a
18	POLR2A	chr21:45884207-45884209	HepG2	liver:	n/a	n/a
19	POLR2A	chr21:45885580-45885940	HepG2	liver:	n/a	n/a
20	POLR2A	chr21:45885819-45886268	HepG2	liver:	n/a	n/a
21	POLR2A	chr21:45884115-45884200	HepG2	liver:	n/a	n/a
22	POLR2A	chr21:45883690-45883719	HepG2	liver:	n/a	n/a
23	POLR2A	chr21:45883848-45883889	HepG2	liver:	n/a	n/a
24	POLR2A	chr21:45885283-45886042	HepG2	liver:	n/a	n/a
25	RFX5	chr21:45883982-45884006	H1-hESC	embryonic stem cell:	n/a	n/a
26	SIX5	chr21:45885369-45885612	K562	blood:	n/a	n/a
27	SRF	chr21:45885334-45885535	GM12878	blood:	n/a	n/a
28	SRF	chr21:45885602-45885858	GM12878	blood:	n/a	n/a
29	TCF12	chr21:45885317-45885851	HepG2	liver:	n/a	n/a
30	USF1	chr21:45885316-45885802	HepG2	liver:	n/a	n/a
31	ZBTB33	chr21:45885257-45885833	GM12878	blood:	n/a	n/a
32	ZBTB33	chr21:45885362-45885838	K562	blood:	n/a	n/a

(count:247 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr21:45884825-45884875	U87	brain:	n/a
2	chr21:45883864-45883914	HCPEpiC	choroid plexus:	n/a
3	chr21:45883590-45883640	NHBE	bronchial:	n/a
4	chr21:45884825-45884875	U87	brain:	n/a
5	chr21:45883864-45883914	HCPEpiC	choroid plexus:	n/a
6	chr21:45883590-45883640	NHBE	bronchial:	n/a
7	chr21:45884825-45884875	Caco-2	colon:	n/a
8	chr21:45883729-45883779	HepG2	liver:	n/a
9	chr21:45883729-45883779	HPAEpiC	pulmonary alveolar:	n/a
10	chr21:45883864-45883914	LNCaP	prostate:	n/a
11	chr21:45883864-45883914	IMR90	lung:	fetal
12	chr21:45883729-45883779	SKMC	muscle:	n/a
13	chr21:45884825-45884875	ECC-1	luminal epithelium:	n/a
14	chr21:45883590-45883640	HPAEpiC	pulmonary alveolar:	n/a
15	chr21:45883864-45883914	T-47D	breast:	n/a
16	chr21:45883864-45883914	PANC-1	pancreas:	n/a
17	chr21:45883864-45883914	HCF	heart:	n/a
18	chr21:45883864-45883914	AG04449	skin:	fetal
19	chr21:45883729-45883779	AG09309	skin:	n/a
20	chr21:45883864-45883914	Caco-2	colon:	n/a
21	chr21:45883864-45883914	NB4	blood:	n/a
22	chr21:45883864-45883914	GM12891	blood:	n/a
23	chr21:45884825-45884875	HPAEpiC	pulmonary alveolar:	n/a
24	chr21:45883729-45883779	GM19239	blood:	n/a
25	chr21:45883864-45883914	HCM	heart:	n/a
26	chr21:45883590-45883640	BE2_C	brain:	n/a
27	chr21:45883590-45883640	HCPEpiC	choroid plexus:	n/a
28	chr21:45883590-45883640	PrEC	prostate:	n/a
29	chr21:45883729-45883779	SK-N-MC	brain:	n/a
30	chr21:45883864-45883914	HAEpiC	amniotic membrane:	n/a
31	chr21:45884825-45884875	SK-N-MC	brain:	n/a
32	chr21:45883864-45883914	MCF10A-Er-Src	breast:	n/a
33	chr21:45884825-45884875	AG04450	lung:	fetal
34	chr21:45883864-45883914	A549	lung:	n/a
35	chr21:45883864-45883914	U87	brain:	n/a
36	chr21:45883864-45883914	BJ	skin:	n/a
37	chr21:45883864-45883914	K562	blood:	n/a
38	chr21:45884825-45884875	HUVEC	blood vessel:	n/a
39	chr21:45883864-45883914	Hela-S3	cervix:	n/a
40	chr21:45883729-45883779	CMK	blood:	n/a
41	chr21:45883864-45883914	GM19239	blood:	n/a
42	chr21:45884825-45884875	ProgFib	skin:	n/a
43	chr21:45883729-45883779	U87	brain:	n/a
44	chr21:45883729-45883779	NB4	blood:	n/a
45	chr21:45883729-45883779	Caco-2	colon:	n/a
46	chr21:45883590-45883640	SAEC	small airway:	n/a
47	chr21:45883590-45883640	GM06990	blood:	n/a
48	chr21:45884825-45884875	HEEpiC	esophagus:	n/a
49	chr21:45883729-45883779	HEK293	kidney:	embryo
50	chr21:45884825-45884875	AoSMC	blood vessel:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr21:45882393..45885151-chr21:45897633..45899803,2	K562	blood:
2	chr21:45880678..45882360-chr21:45884441..45886620,2	K562	blood:
3	chr21:45876142..45878920-chr21:45886862..45888726,2	MCF-7	breast:
4	chr21:45875495..45879436-chr21:45881615..45885234,3	K562	blood:
5	chr21:45875194..45876834-chr21:45884507..45886571,2	MCF-7	breast:

(count:8 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LRRC3-3	chr21:45885418-45885811	NONHSAT082526
2	lnc-LRRC3-3	chr21:45886057-45886068	NONHSAT082526
3	lnc-LRRC3-3	chr21:45886053-45886073	NONHSAT082525
4	lnc-LRRC3-3	chr21:45885234-45885769	NONHSAT082525
5	lnc-LRRC3-3	chr21:45886057-45886068	NONHSAT082527
6	lnc-LRRC3-3	chr21:45885567-45886307	NONHSAT082524
7	lnc-LRRC3-3	chr21:45885105-45885499	NONHSAT082524
8	lnc-LRRC3-3	chr21:45885418-45885951	NONHSAT082527

No data

Variant related genes	Relation type
MTND6P21	TF binding region
MTND6P21	CpG island
ENSG00000160233	chromatin interactions

Extended variants
information (count: 257 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:257 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs527928935	chr21:45883450-45883451	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs577899464	chr21:45883511-45883512	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs8132982	chr21:45883535-45883536	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs540434472	chr21:45883592-45883593	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs376961758	chr21:45883595-45883596	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs565035078	chr21:45883615-45883616	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs540325976	chr21:45883648-45883649	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs545319264	chr21:45883662-45883663	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs577228033	chr21:45883675-45883676	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs563515855	chr21:45883676-45883677	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs145887743	chr21:45883695-45883696	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs530685491	chr21:45883712-45883713	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs548306667	chr21:45883723-45883724	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs138501266	chr21:45883730-45883731	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs559812723	chr21:45883739-45883740	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs527345239	chr21:45883742-45883743	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs552368120	chr21:45883762-45883763	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs187923129	chr21:45883776-45883777	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs17004648	chr21:45883798-45883799	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs560849846	chr21:45883802-45883803	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs150305526	chr21:45883812-45883813	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs373662878	chr21:45883820-45883821	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs192654041	chr21:45883835-45883836	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs535475451	chr21:45883870-45883871	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs554086347	chr21:45883890-45883891	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs375765214	chr21:45883958-45883959	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs183380454	chr21:45883999-45884000	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs572584265	chr21:45884041-45884042	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs77030080	chr21:45884042-45884043	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs558812038	chr21:45884045-45884046	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs577091808	chr21:45884046-45884047	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs544531535	chr21:45884059-45884060	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs562632028	chr21:45884106-45884107	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs561008683	chr21:45884136-45884137	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs8132854	chr21:45884137-45884138	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs75814624	chr21:45884194-45884195	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs8132972	chr21:45884225-45884226	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
38	rs551833359	chr21:45884261-45884262	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs564372498	chr21:45884286-45884287	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs79766373	chr21:45884296-45884297	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs550495020	chr21:45884297-45884298	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs568660332	chr21:45884318-45884319	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs529553399	chr21:45884337-45884338	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs187358795	chr21:45884366-45884367	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs566052710	chr21:45884378-45884379	Weak transcription Enhancers Bivalent Enhancer Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs192265368	chr21:45884451-45884452	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs576682457	chr21:45884470-45884471	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs137931853	chr21:45884507-45884508	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs184374663	chr21:45884542-45884543	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs570701975	chr21:45884544-45884545	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	21858162	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	18628472	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Ewing''s sarcoma	21437220	CNVD
Lung adenocarcinoma	17086460	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute myeloid leukemia	21358987	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	23341502	CNVD
Ovarian cancer	21720365	CNVD
Urothelial carcinoma	21177765	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	21251322	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	17142309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Ewing''s sarcoma	18628472	CNVD
Leukemia	18628472	CNVD
small cell lung cancer	17426248	CNVD
Developmental delay	21147756	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:52 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:45876400-45883800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
2	chr21:45876600-45883800	Weak transcription	Duodenum Smooth Muscle	Duodenum
3	chr21:45878200-45890400	Weak transcription	Rectal Mucosa Donor 29	rectum
4	chr21:45879400-45886600	Weak transcription	Fetal Brain Male	brain
5	chr21:45879400-45887800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr21:45879600-45883600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
7	chr21:45880400-45884200	Enhancers	Fetal Muscle Leg	muscle
8	chr21:45881800-45884200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
9	chr21:45881800-45884400	Strong transcription	Fetal Intestine Small	intestine
10	chr21:45881800-45911800	Weak transcription	Right Atrium	heart
11	chr21:45882000-45886000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr21:45882200-45885000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
13	chr21:45882200-45886400	Weak transcription	Spleen	Spleen
14	chr21:45882400-45883600	Enhancers	Fetal Muscle Trunk	muscle
15	chr21:45882400-45883800	Weak transcription	Brain Germinal Matrix	brain
16	chr21:45882400-45886800	Weak transcription	Liver	Liver
17	chr21:45882600-45884200	Enhancers	Ovary	ovary
18	chr21:45882800-45885200	Weak transcription	Right Ventricle	heart
19	chr21:45883000-45884600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr21:45883000-45897200	Weak transcription	Fetal Brain Female	brain
21	chr21:45883200-45883600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
22	chr21:45883200-45883600	Enhancers	Stomach Smooth Muscle	stomach
23	chr21:45883200-45884400	Enhancers	Breast Myoepithelial Primary Cells	Breast
24	chr21:45883400-45883600	Enhancers	Brain Angular Gyrus	brain
25	chr21:45883400-45883600	Enhancers	Colon Smooth Muscle	Colon
26	chr21:45883400-45883600	Enhancers	Fetal Lung	lung
27	chr21:45883400-45884000	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr21:45883400-45884000	Enhancers	Cortex derived primary cultured neurospheres	brain
29	chr21:45883400-45884400	Bivalent Enhancer	Adipose Nuclei	Adipose
30	chr21:45883600-45884000	Active TSS	Stomach Smooth Muscle	stomach
31	chr21:45883600-45884400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
32	chr21:45883800-45884000	Active TSS	Duodenum Smooth Muscle	Duodenum
33	chr21:45883800-45884200	Bivalent Enhancer	Brain Cingulate Gyrus	brain
34	chr21:45883800-45884200	Enhancers	Brain Germinal Matrix	brain
35	chr21:45884000-45897200	Weak transcription	Stomach Smooth Muscle	stomach
36	chr21:45884200-45884400	Enhancers	Brain Inferior Temporal Lobe	brain
37	chr21:45884400-45896400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
38	chr21:45884400-45898600	Weak transcription	Fetal Intestine Small	intestine
39	chr21:45884600-45887600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr21:45885000-45885800	Strong transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
41	chr21:45885200-45885800	Bivalent/Poised TSS	Fetal Kidney	kidney
42	chr21:45885800-45887800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
43	chr21:45886000-45886200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
44	chr21:45886000-45887800	ZNF genes & repeats	Foreskin Melanocyte Primary Cells skin01	Skin
45	chr21:45886200-45886400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
46	chr21:45886200-45887000	ZNF genes & repeats	Foreskin Fibroblast Primary Cells skin01	Skin
47	chr21:45886400-45886600	Enhancers	Spleen	Spleen
48	chr21:45886600-45890200	Weak transcription	Spleen	Spleen
49	chr21:45886800-45888200	Enhancers	Liver	Liver
50	chr21:45887600-45888000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links